mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States

The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized to offer broader protection against COVID-19. We conducted a matched cohort study to evaluate the effectiveness of the bivalent vaccine in preventing hospitalization for COVID-19 (primary outcome) and medically a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Hung Fu, Ackerson, Bradley K., Sy, Lina S., Tubert, Julia E., Luo, Yi, Qiu, Sijia, Lee, Gina S., Bruxvoort, Katia J., Ku, Jennifer H., Florea, Ana, Takhar, Harpreet S., Bathala, Radha, Zhou, Cindy Ke, Esposito, Daina B., Marks, Morgan A., Anderson, Evan J., Talarico, Carla A., Qian, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511551/
https://www.ncbi.nlm.nih.gov/pubmed/37730701
http://dx.doi.org/10.1038/s41467-023-41537-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511551/
https://www.ncbi.nlm.nih.gov/pubmed/37730701
http://dx.doi.org/10.1038/s41467-023-41537-7

Ejemplares similares